5F12 AD3
5F12 AD3
规格:
货期:
编号:TS212825
品牌:Testobio
| 产品名称： | 5F12 AD3 |
|---|---|
| 商品货号： | TS212825 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with a polypeptide having the sequence NH2-Ala-Pro-Pro-Arg-Leu-Ile-Cys-Asp-Ser-Arg-Val-Leu-Glu-Arg-Tyr-Leu-Leu-Glu-Ala-Lys-COOH. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against erythropoietin |
| Cellular Products： | immunoglobulin; monoclonal antibody; against erythropoietin |
| Comments： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with a polypeptide having the sequence NH2-Ala-Pro-Pro-Arg-Leu-Ile-Cys-Asp-Ser-Arg-Val-Leu-Glu-Arg-Tyr-Leu-Leu-Glu-Ala-Lys-COOH. |
| Complete Growth Medium： | Culture Medium: Iscoves modified Dulbeccos medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2xa0x 105 cells/mL and maintain between 1 X 105 and 1 X 106 cells/mL. |
| Cryopreservation： | Freeze Medium: Complete growth medium supplemented with 5% (v/v) DMSO |
| Isotype： | IgG1 |
| Name of Depositor： | Amgen, Inc., Kirin-Amgen, Inc. |
| U.S. Patent Number： | |
| References： | Lin FK. DNA sequences encoding erythropoietin. US Patent 4,703,008 dated Oct 27 1987 Egrie JC. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin. US Patent 4,558,006 dated Dec 10 1985 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
5F12 AD3
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 5F12 AD3 |
|---|---|
| 商品货号： | TS212825 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with a polypeptide having the sequence NH2-Ala-Pro-Pro-Arg-Leu-Ile-Cys-Asp-Ser-Arg-Val-Leu-Glu-Arg-Tyr-Leu-Leu-Glu-Ala-Lys-COOH. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against erythropoietin |
| Cellular Products： | immunoglobulin; monoclonal antibody; against erythropoietin |
| Comments： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with a polypeptide having the sequence NH2-Ala-Pro-Pro-Arg-Leu-Ile-Cys-Asp-Ser-Arg-Val-Leu-Glu-Arg-Tyr-Leu-Leu-Glu-Ala-Lys-COOH. |
| Complete Growth Medium： | Culture Medium: Iscoves modified Dulbeccos medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2xa0x 105 cells/mL and maintain between 1 X 105 and 1 X 106 cells/mL. |
| Cryopreservation： | Freeze Medium: Complete growth medium supplemented with 5% (v/v) DMSO |
| Isotype： | IgG1 |
| Name of Depositor： | Amgen, Inc., Kirin-Amgen, Inc. |
| U.S. Patent Number： | |
| References： | Lin FK. DNA sequences encoding erythropoietin. US Patent 4,703,008 dated Oct 27 1987 Egrie JC. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin. US Patent 4,558,006 dated Dec 10 1985 |
